![Omid Farokhzad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Omid Farokhzad
Chief Executive Officer at
SEER, INC.
Net worth: 8 M $ as of 2026-05-30
Profile
Founder of 5 different companies, among them: Seer, Inc. (California), Selecta Biosciences, Inc. and DNIB Unwind, Inc. Omid C. Farokhzad is an entrepreneur and is Chairman & Chief Executive Officer for Seer, Inc. (California) (which he founded in 2017). He is also on the board of Placon Therapeutics, Inc. In his past career he was Chairman for Selecta Biosciences, Inc. (he founded the company in 2007), Associate Professor at Harvard Medical School, Director at DNIB Unwind, Inc. and Director at Tarveda Therapeutics, Inc. Dr. Farokhzad received a doctorate and a graduate degree from Boston University School of Medicine and an MBA from Massachusetts Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SEER, INC. CLASS A 8.01% | 2026-05-10 | 4,403,724 ( 8.01% ) | 8 M $ | 2026-05-30 |
Latest news about Omid Farokhzad
Omid Farokhzad active positions
| Companies | Position | Start |
|---|---|---|
| SEER, INC. | Chief Executive Officer | 2018-02-28 |
Placon Therapeutics, Inc.
 Placon Therapeutics, Inc. BiotechnologyHealth Technology Develops novel platinum therapies | Director/Board Member | - |
Xlink Therapeutics, Inc. | Founder | - |
PrognomIQ, Inc.
 PrognomIQ, Inc. Medical SpecialtiesHealth Technology Develops and commercializes multi-omics human tests for cancer and other diseases | Founder | - |
Xira Connect, Inc. | Director/Board Member | 2019-07-31 |
Former positions of Omid Farokhzad
| Companies | Position | End |
|---|---|---|
Senti Biosciences, Inc.
 Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Director/Board Member | 2024-11-24 |
| DYNC SPL | Chairman | 2022-05-31 |
| CARTESIAN THERAPEUTICS, INC. | Founder | 2019-11-18 |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Founder | 2018-12-31 |
| ░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Omid Farokhzad
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
58
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
Semaphore, Inc.
 Semaphore, Inc. Packaged SoftwareTechnology Services Develops and distributes advanced financial and project management software | Technology Services |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Medicine
 Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Placon Therapeutics, Inc.
Placon Therapeutics, Inc. BiotechnologyHealth Technology Develops novel platinum therapies | Health Technology |
Seer, Inc. (California)
 Seer, Inc. (California) BiotechnologyHealth Technology Provides research and development services for biotechnology | Health Technology |
PrognomIQ, Inc.
PrognomIQ, Inc. Medical SpecialtiesHealth Technology Develops and commercializes multi-omics human tests for cancer and other diseases | Health Technology |
Dynamics Special Purpose Corp.
 Dynamics Special Purpose Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Xlink Therapeutics, Inc. | |
Xira Connect, Inc. | |
Senti Biosciences, Inc.
Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Health Technology |
- Stock Market
- Insiders
- Omid Farokhzad
